Squarepoint’s Cellebrite CLBT Stock Holding History

Squarepoint’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$981K	Sell	67,185 -66,713	-50%	-$882K	﹤0.01%	2910
2026 Q1	$1.85M	Buy	+133,898	New	+$2.02M	﹤0.01%	2235
2025 Q4	–	Sell	-32,737	Closed	-$607K	–	4338
2025 Q3	$607K	Sell	32,737 -9,462	-22%	-$149K	﹤0.01%	3086
2025 Q2	$675K	Buy	+42,199	New	+$752K	﹤0.01%	3015
2024 Q4	–	Sell	-14,006	Closed	-$236K	–	5061
2024 Q3	$236K	Sell	14,006 -36,683	-72%	-$544K	﹤0.01%	3596
2024 Q2	$606K	Sell	50,689 -30,659	-38%	-$343K	﹤0.01%	2930
2024 Q1	$901K	Sell	81,348 -267,906	-77%	-$2.73M	﹤0.01%	2671
2023 Q4	$3.02M	Buy	349,254 +132,512	+61%	+$1.03M	0.01%	1725
2023 Q3	$1.66M	Buy	216,742 +101,861	+89%	+$765K	﹤0.01%	1959
2023 Q2	$827K	Buy	+114,881	New	+$670K	﹤0.01%	2305

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Squarepoint's CLBT Position: Q2 2026 in Review

Squarepoint reduced its Cellebrite (CLBT) stake by 50% in Q2 2026, selling an estimated $882K and leaving 67,185 shares worth $981K. The position accounts for ﹤0.01% of the portfolio, ranked #2910.

Squarepoint first reported a position in CLBT in Q2 2023 and has held it in 10 quarters since. The position peaked at $3.02M in Q4 2023. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Squarepoint held 67,185 shares of Cellebrite worth $981K as of Q2 2026.
Squarepoint sold 66,713 Cellebrite shares in Q2 2026, an estimated $882K.
Cellebrite made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2910 holding.
Squarepoint first reported a position in Cellebrite in Q2 2023 and has held it in 10 quarters since.
Squarepoint's Cellebrite position peaked at $3.02M in Q4 2023.
200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.